STORY FROM: MDL Mass Tort & Class Action Monitor

Fla. Man Says Contaminated Zantac Caused Rare Cancer

MIAMI — A Florida man has sued the maker of Zantac in Florida state court, alleging it concealed the fact that its acid reflux drug Zantac (ranitidine) contained “incredibly high levels” of a probable human carcinogen.

In a complaint filed Sept. 13 in the Miami-Dade County Circuit Court, Joseph Galimidi says Sanofi Aventis knew Zantac was “laden” with n-nitrososdimethylamine (NDMA), yet failed to inform the FDA, physicians and the public of that known risk.

NDMA is classified a probable human carcinogen by the Department of Environmental Protection and was formerly used in the production of liquid rocket fuel. According ...

Associated Law Firms
Levin Citron Rodal

Registered User Login